Advertisement

Topics

Valeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

16:43 EDT 29 Oct 2018 | BioPortfolio Report Blog

Valeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Valeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Valeant Pharmaceuticals International, Inc. Valeant or 'the company' is a pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. The company markets a range of pharmaceutical products, medical devices and OTC products primarily in the areas of dermatology, gastrointestinal disorders, eye health and neurology. The key products of the company include contact lenses, intraocular lenses, ophthalmic surgical equipment, aesthetics devices, overthecounter OTC products, gastrointestinal products, dermatological products, and Lotemax Gel. The company markets its products in the North America, Europe, the Middle East, Latin America, Asia Pacific and Africa. Valeant is headquartered in Quebec, Canada.


Scope


Detailed information on Valeant Pharmaceuticals International, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Valeant Pharmaceuticals International, Inc. in the form of a SWOT analysis

An indepth view of the business model of Valeant Pharmaceuticals International, Inc. including a breakdown and examination of key business segments

Intelligence on Valeant Pharmaceuticals International, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Valeant Pharmaceuticals International, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Valeant Pharmaceuticals International, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Valeant Pharmaceuticals International, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Valeant Pharmaceuticals International, Inc.'s business structure, strategy and prospects.

Original Article: Valeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Valeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...